Gene Therapies

Jul 22, 2026

For most of modern medical history, treatment has meant managing disease, controlling symptoms, slowing progression, and buying time. Regenerative medicine flips that model on its head. Instead of managing damage, it aims to repair it: regrowing tissue, replacing diseased cells, and in some cases, reversing conditi...

Jun 03, 2026

It costs, on average, $2.6 billion and over a decade to bring a single drug to market. Roughly 90% of drug candidates fail in clinical trials. And yet, the pressure to innovate faster, spend smarter, and outmanoeuvre competitors has never been more intense. Molecular modelling isn't just a scientist's tool anymore....

May 20, 2026

Plasmid DNA has moved from being a specialized laboratory tool to becoming one of the most strategic raw materials in modern biopharmaceutical manufacturing. In simple terms, a plasmid is a small, circular DNA molecule that exists separately from chromosomal DNA and can replicate independently inside microbial host...

Dec 19, 2025

In a landmark decision on December 10, 2025, the FDA approved WASKYRA (etuvetidigene autotemcel), marking a transformative milestone in the treatment of Wiskott-Aldrich syndrome—a rare, life-threatening genetic blood disorder. This approval represents not only a significant advancement in gene therapy but also a hi...

Jan 24, 2025

The 43rd Annual J.P. Morgan Healthcare Conference in 2025 showcased the accelerating progress of cell and gene therapies, reaffirming their transformative potential in modern medicine. Despite prior challenges, the field is now demonstrating tangible success, heralding a new era in treating complex and previously u...

Oct 23, 2024

Plasma protein therapeutics are revolutionizing the landscape of modern medicine by harnessing the healing potential of the human body. Derived from donated blood plasma, these life-saving treatments are packed with antibodies, clotting factors, and other essential proteins that help manage a wide array of conditio...

Aug 23, 2024

Neuromuscular disorders (NMD) encompass a broad spectrum of conditions impacting the peripheral nervous system, which comprises all motor and sensory nerves linking the brain and spinal cord to the body. These disorders comprise various classes of diseases, such as muscular dystrophies, myopathies, motor neuron dis...

Mar 04, 2024

Gene therapy is becoming a promising solution for retinal degenerative illnesses, particularly because the retina offers an excellent avenue for studying and treating eye-related issues. Importantly, it is the first tissue in the United States to receive approval for gene therapy in cases of inherited disorders. ...

Feb 05, 2024

Gene therapy is an innovative medical approach that manipulates an individual’s genetic material to prevent or treat diseases. It primarily involves introducing, modifying, or substituting genes within a patient’s cells. The central objective of gene therapy is to rectify genetic abnormalities, insert missing genes...

Oct 27, 2023

Hemophilia B is a rare genetic bleeding disorder in which affected individuals have insufficient levels of a blood protein called factor IX. Around 3 in 100 individuals with hemophilia B produce an antibody to the factor IX replacement therapy used to treat or avoid their bleeding episodes, called an inhibitor. The...